(Q24296826)

GOA release 2020-03-11

phosphatase activity

1 reference

Soluble epoxide hydrolase

GOA release 2020-03-11

0 references

author name string

Punit K Srivastava

1

0 references

Vikas K Sharma

2

0 references

Davendra S Kalonia

3

0 references

David F Grant

Archives of Biochemistry and Biophysics

4

0 references

language of work or name

English

0 references

publication date

15 July 2004

0 references

published in

0 references

volume

427

0 references

issue

2

0 references

page(s)

164-9

0 references

cites work

cDNA cloning and expression of a soluble epoxide hydrolase from human liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Improved radiolabeled substrates for soluble epoxide hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Catabolism of epoxy fatty esters by the purified epoxide hydrolase from mouse and human liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

The effect of pH and temperature on the self-association of recombinant human interleukin-2 as studied by equilibrium sedimentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Drug methylation in cancer therapy: lessons from the TPMT polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Overexpression of C-terminal Src kinase blocks 14, 15-epoxyeicosatrienoic acid-induced tyrosine phosphorylation and mitogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Gene evolution of epoxide hydrolases and recommended nomenclature

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Polymorphisms in human soluble epoxide hydrolase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: The Coronary Artery Risk Development in Young Adults (CARDIA) study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

5,6-epoxyeicosatrienoic acid mediates the enhanced renal vasodilation to arachidonic acid in the SHR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ABB.2004.05.003

7 January 2021

10.1016/J.ABB.2004.05.003

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zujwrzf3grc4hjqpbybgwnpihe

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_zujwrzf3grc4hjqpbybgwnpihe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zujwrzf3grc4hjqpbybgwnpihe

30 July 2022

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1481295

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1481295

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/zujwrzf3grc4hjqpbybgwnpihe

30 July 2022